<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>44(2)</volume><submitter>Nataprawira HM</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Data on childhood and adolescent multidrug/rifampicin-resistant tuberculosis (MDR/RR-TB) in Indonesia are lacking. We aimed to assess clinical features, adverse events (AEs) and treatment outcomes of childhood and adolescent MDR/RR-TB.&lt;h4>Methods&lt;/h4>A retrospective cohort study was performed in children and adolescents &lt;18 years old treated for MDR/RR-TB at Hasan Sadikin General Hospital in Bandung, Indonesia, between June 2016 and March 2024. Multivariable logistic regression analyses were used to calculate adjusted odds ratios (aOR) for predictors of all-cause mortality.&lt;h4>Results&lt;/h4>Among 84 included patients, 69 (82%) were adolescents 10-17 years of age, 54 (64%) were female, 54 (64%) were malnourished and 55 (65%) had culture-confirmed disease. Among 69 (82%) pat</pubmed_abstract><journal>The Pediatric infectious disease journal</journal><pagination>143-150</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11731024</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical Features, Adverse Events and Treatment Outcomes of Multidrug/Rifampicin-resistant Tuberculosis in Children and Adolescents: An Eight-year Retrospective Cohort Study in Bandung, Indonesia.</pubmed_title><pmcid>PMC11731024</pmcid><pubmed_authors>Nataprawira HM</pubmed_authors><pubmed_authors>Ruslami R</pubmed_authors><pubmed_authors>Menzies D</pubmed_authors><pubmed_authors>Gafar F</pubmed_authors><pubmed_authors>Sari CA</pubmed_authors><pubmed_authors>Alffenaar JC</pubmed_authors><pubmed_authors>Marais BJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical Features, Adverse Events and Treatment Outcomes of Multidrug/Rifampicin-resistant Tuberculosis in Children and Adolescents: An Eight-year Retrospective Cohort Study in Bandung, Indonesia.</name><description>&lt;h4>Background&lt;/h4>Data on childhood and adolescent multidrug/rifampicin-resistant tuberculosis (MDR/RR-TB) in Indonesia are lacking. We aimed to assess clinical features, adverse events (AEs) and treatment outcomes of childhood and adolescent MDR/RR-TB.&lt;h4>Methods&lt;/h4>A retrospective cohort study was performed in children and adolescents &lt;18 years old treated for MDR/RR-TB at Hasan Sadikin General Hospital in Bandung, Indonesia, between June 2016 and March 2024. Multivariable logistic regression analyses were used to calculate adjusted odds ratios (aOR) for predictors of all-cause mortality.&lt;h4>Results&lt;/h4>Among 84 included patients, 69 (82%) were adolescents 10-17 years of age, 54 (64%) were female, 54 (64%) were malnourished and 55 (65%) had culture-confirmed disease. Among 69 (82%) pat</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-06-01T05:04:25.426Z</modification><creation>2025-04-06T01:17:21.605Z</creation></dates><accession>S-EPMC11731024</accession><cross_references><pubmed>39312636</pubmed><doi>10.1097/INF.0000000000004539</doi></cross_references></HashMap>